153
Participants
Start Date
November 26, 2020
Primary Completion Date
August 25, 2025
Study Completion Date
August 25, 2025
JNJ-74856665
JNJ-74856665 will be administered orally.
AZA
AZA will be administered IV infusion or SC injection.
VEN
VEN tablet will be administered orally.
Seoul National University Hospital, Seoul
Hosp Univ Fund Jimenez Diaz, Madrid
Clinica Univ. de Navarra, Pamplona
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse
Centre Hospitalier Universitaire (CHU) de Bordeaux Hopital HautLeveque Centre Francois Magendie, Pessac
CHRU Tours Hopital Bretonneau, Tours
Hosp. Univ. Marques de Valdecilla, Santander
Hopital Saint Louis, Paris
CHU de Nice Hopital de l Archet, Nice
Severance Hospital Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
The Catholic University of Korea Seoul St Marys Hospital, Seoul
Hosp Univ Vall D Hebron, Barcelona
Hosp Clinic de Barcelona, Barcelona
Inst. Cat. Doncologia-H Duran I Reynals, Barcelona
Leicester Royal Infirmary, Leicester
University College London Hospitals, London
Kings College Hospital, London
The Christie Nhs Foundation Trust, Manchester
Janssen Research & Development, LLC
INDUSTRY